Vylibra
Product Images NDC 53002-1777

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vylibra (NDC 53002-1777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021777)

FDA Label Image

Norgestimate-fig1 (Norgestimate Fig1)

FDA Label Image

Norgestimate-fig2 (Norgestimate Fig2)

FDA Label Image

Fig3 (Norgestimate Fig3)

Fig3 (Norgestimate Fig3)
This text appears to describe different methods of birth control and their effectiveness rates in preventing pregnancy. It also shows the range of pregnancy rates that occur for women who do not use any form of birth control. The listed methods of birth control include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, withdrawal, and no sex during the most fertile days of the monthly cycle.*
FDA Label Image

Norgestimate-fig4 (Norgestimate Fig4)

FDA Label Image

Norgestimate-fig5 (Norgestimate Fig5)

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical Structure (Norgestimate Str)
Ethinyl Estradiol is a synthetic estrogen commonly used in combination with progestin as a component of hormonal contraceptives. It works by preventing ovulation and altering the cervical mucus to prevent sperm from reaching the egg. It may also be used to treat some menopausal symptoms, certain types of cancer, and acne.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.